Literature DB >> 9032506

Respiratory dysfunction in multiple sclerosis: a prospective analysis of 60 patients.

B Buyse1, M Demedts, J Meekers, L Vandegaer, F Rochette, L Kerkhofs.   

Abstract

This study aimed to determine the relationship between pulmonary function, respiratory muscle function and neurological function in multiple sclerosis (MS). Sixty patients (27 males and 33 females) aged 27-75 yrs (mean +/- SD 48 +/- 12 yrs) were prospectively studied. The Kurtzke Expanded Disability Status Scale (EDSS; range 0-10) score was 6.5 +/- 1.5; and the different Functional Systems Scores (FSS; ranges 0-5 and 0-6) were: pyramidal 3.4 +/- 1.1; brain stem 1.9 +/- 1.2; mental 1.3 +/- 0.9; cerebellar 2.2 +/- 1.0; sphincter 1.8 +/- 1.5; visual 1.4 +/- 1.4; and sensory 2.0 +/- 1.5. Results of lung function tests were: vital capacity (VC) 80 +/- 23% of predicted; single-breath transfer factor of the lung for carbon monoxide (TL, CO, sb) 83 +/- 17% pred; maximal static expiratory mouth pressure (MEP) 30 +/- 16% pred; and maximal static inspiratory mouth pressure (MIP) 47 +/- 23% pred, indicating a marked respiratory muscle dysfunction, with a minor restrictive defect. In 70% of the patients, a transcutaneous oxygen saturation (Stc, O2) of less than 92% at night was found. Comparison of lung function and disability scores showed that the abnormalities in both tended to be correlated to each other, and that this was significant for EDSS versus lung volumes, for most FSS with VC, and also for some FSS with MEP and/or MIP. Duration of disease was significantly correlated with the EDSS, but not with the different FSS scores (with the exception of mental status) and not with lung function. Multiple sclerosis leads to lung function abnormalities attributable to respiratory pump dysfunction.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9032506     DOI: 10.1183/09031936.97.10010139

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  13 in total

1.  Effects of a 10-week inspiratory muscle training program on lower-extremity mobility in people with multiple sclerosis: a randomized controlled trial.

Authors:  Lucinda Pfalzer; Donna Fry
Journal:  Int J MS Care       Date:  2011

2.  Six-minute walk test for persons with mild or moderate disability from multiple sclerosis: performance and explanatory factors.

Authors:  Jane L Wetzel; Donna K Fry; Lucinda A Pfalzer
Journal:  Physiother Can       Date:  2011-04-13       Impact factor: 1.037

3.  Ventilatory impairment in the dysmyelinated Long Evans shaker rat.

Authors:  R A Johnson; T L Baker-Herman; I D Duncan; G S Mitchell
Journal:  Neuroscience       Date:  2010-06-11       Impact factor: 3.590

Review 4.  Exercise and multiple sclerosis.

Authors:  Lesley J White; Rudolph H Dressendorfer
Journal:  Sports Med       Date:  2004       Impact factor: 11.136

5.  Cervical spinal demyelination with ethidium bromide impairs respiratory (phrenic) activity and forelimb motor behavior in rats.

Authors:  N L Nichols; A M Punzo; I D Duncan; G S Mitchell; R A Johnson
Journal:  Neuroscience       Date:  2012-11-14       Impact factor: 3.590

Review 6.  Respiratory aspects of neurological disease.

Authors:  M I Polkey; R A Lyall; J Moxham; P N Leigh
Journal:  J Neurol Neurosurg Psychiatry       Date:  1999-01       Impact factor: 10.154

Review 7.  Common mechanisms of compensatory respiratory plasticity in spinal neurological disorders.

Authors:  Rebecca A Johnson; Gordon S Mitchell
Journal:  Respir Physiol Neurobiol       Date:  2013-05-28       Impact factor: 1.931

8.  Pulmonary Function and Respiratory Muscle Strength in Patients with Multiple Sclerosis.

Authors:  Elisabeth Westerdahl; Martin Gunnarsson; Anna Wittrin; Ylva Nilsagård
Journal:  Mult Scler Int       Date:  2021-06-14

9.  Lung volume recruitment in multiple sclerosis.

Authors:  Nadim Srour; Carole LeBlanc; Judy King; Douglas A McKim
Journal:  PLoS One       Date:  2013-01-31       Impact factor: 3.240

10.  Standing up in multiple sclerosis (SUMS): protocol for a multi-centre randomised controlled trial evaluating the clinical and cost effectiveness of a home-based self-management standing frame programme in people with progressive multiple sclerosis.

Authors:  J A Freeman; W Hendrie; S Creanor; L Jarrett; A Barton; C Green; J Marsden; E Rogers; J Zajicek
Journal:  BMC Neurol       Date:  2016-05-05       Impact factor: 2.474

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.